98%
921
2 minutes
20
Medicare Advantage healthcare plans may present undue impediments that result in disparities in patient outcomes. This study aims to compare the outcomes of patients who underwent STS resection based on enrollment in either traditional Medicare (TM) or Medicare Advantage (MA) plans. The Premier Healthcare Database was utilized to identify all patients ≥65 years old who underwent surgery for resection of a lower-extremity STS from 2015 to 2021. These patients were then subdivided based on their Medicare enrollment status (i.e., TM or MA). Patient characteristics, hospital factors, and comorbidities were recorded for each cohort. Bivariable analysis was performed to assess the 90-day risk of postoperative complications. Multivariable analysis controlling for patient sex, as well as demographic and hospital factors found to be significantly different between the cohorts, was also performed. From 2015 to 2021, 1858 patients underwent resection of STS. Of these, 595 (32.0%) had MA coverage and 1048 (56.4%) had TM coverage. The only comorbidities with a significant difference between the cohorts were peripheral vascular disease ( = 0.027) and hypothyroidism ( = 0.022), both with greater frequency in MA patients. After controlling for confounders, MA trended towards having significantly higher odds of pulmonary embolism (adjusted odds ratio (aOR): 1.98, 95% confidence interval (95%-CI): 0.58-6.79), stroke (aOR: 1.14, 95%-CI: 0.20-6.31), surgical site infection (aOR: 1.59, 95%-CI: 0.75-3.37), and 90-day in-hospital death (aOR 1.38, 95%-CI: 0.60-3.19). Overall, statistically significant differences in postoperative outcomes were not achieved in this study. The authors of this study hypothesize that this may be due to study underpowering or the inability to control for other oncologic factors not available in the Premier database. Further research with higher power, such as through multi-institutional collaboration, is warranted to better assess if there truly are no differences in outcomes by Medicare subtype for this patient population.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420157 | PMC |
http://dx.doi.org/10.3390/jcm12155122 | DOI Listing |
JAMA Intern Med
September 2025
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Importance: Hospitals have reported growing difficulty in discharging patients in a timely manner, often citing bottlenecks in postacute care. Medicare Advantage plans, now the dominant form of Medicare coverage, may contribute to these delays due to administrative and network constraints, yet national evidence is lacking.
Objective: To quantify changes in hospital length of stay for Medicare Advantage vs traditional Medicare beneficiaries.
Health Aff Sch
September 2025
Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA 90095, United States.
Introduction: The Medicare Advantage (MA) payment system gives rise to incentives for plans to attract and retain beneficiaries from minoritized racial and ethnic groups and those dually eligible for Medicaid (duals) by offering these groups additional benefits.
Methods: We examined how MA plans respond to these incentives using a 2020 policy change that granted broader flexibility in benefit design, allowing plans to offer Special Supplemental Benefits for the Chronically Ill (SSBCI).
Results: We found that plans with higher shares of patients from these groups were more likely to offer SSBCI benefits: a 1 SD increase in a plan's non-White share was associated with a 20.
Circ Cardiovasc Qual Outcomes
September 2025
Division of Cardiology, Richard and Susan Smith Center for Outcomes Research, Beth Israel Deaconess Medical and Harvard Medical School, Boston, MA.
J Gen Intern Med
September 2025
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Background: The Affordable Care Act expanded Medicaid eligibility for low-income adults who are not Medicare eligible while leaving in place states' more restrictive dual eligibility criteria. When Medicaid expansion enrollees turn 65 and transition to Medicare as their primary insurer, they may lose Medicaid and face higher premiums and out-of-pocket costs, yet there is little understanding of how older adults navigate this change in insurance programs.
Objective: To investigate the experiences of Medicaid expansion enrollees who transitioned to Medicare coverage at age 65.
Alzheimers Dement Behav Socioecon Aging
June 2025
Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.
Introduction: Medicare Advantage (MA) plan selection may differ between older adults with or without dementia in unexplored ways. This study aims to characterize MA plan choice among those with dementia.
Methods: We used the 2010 to 2018 waves of the Health and Retirement Study with linked Medicare enrollment data to identify MA respondents ≥ 65 years, with and without dementia.